1D | -0.2 % |
1W | 2.0 % |
2W | 0.4 % |
1M | -0.6 % |
3M | 1.9 % |
6M | -40.5 % |
9M | -37.3 % |
1Y | -39.1 % |
Alpha
-52.7%
|
Beta
0.55
|
sharpe-R
-0.78
|
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
|
sharpe-R Benchmark
2.16
|
Calculation Frequency | Daily |
Latest Valuation Time | 2024-09-18 07:49:53 |
Launch Date | 2023-01-01 00:00:00 |
First Valuation Date | 2021-01-01 00:00:00 |
Max. DrawDown | -50.18% |
Max. DrawDown Benchmark | -8.41% |
This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.
The assets selection in this portfolio is based on: Macro-Pattern Mix St..Try Our Peformance Checker Tool
Asset | Asset Class | Action | Weight | Entry Price | Current Price | PnL | Entry Date |
---|---|---|---|---|---|---|---|
PODD Insulet Corporation | Equity | Buy | 9.83% | 15.22% | 2024-08-29 | ||
ESPR Esperion Therapeutics, Inc. | Equity | Buy | 8.73% | -2.73% | 2024-09-02 | ||
NVCR NovoCure Limited | Equity | Buy | 7.77% | -0.17% | 2024-09-06 | ||
MYGN Myriad Genetics, Inc. | Equity | Buy | 7.82% | 6.04% | 2024-09-09 | ||
LMAT LeMaitre Vascular, Inc. | Equity | Sell | -3.72% | 0.25% | 2024-08-29 | ||
AVXL Anavex Life Sciences Corp. | Equity | Sell | -3.47% | 7.14% | 2024-08-29 | ||
CERS Cerus Corporation | Equity | Sell | -3.73% | 6.64% | 2024-09-05 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
PODD Insulet Corporation | Buy | 9.83% | 15.22% | 2024-08-29 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.73% | -2.73% | 2024-09-02 |
NVCR NovoCure Limited | Buy | 7.77% | -0.17% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.82% | 6.04% | 2024-09-09 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.72% | 0.25% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.47% | 7.14% | 2024-08-29 |
CERS Cerus Corporation | Sell | -3.73% | 6.64% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
STAA | Buy All | 0.59% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
PODD Insulet Corporation | Buy | 9.82% | 14.42% | 2024-08-29 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.69% | -3.83% | 2024-09-02 |
NVCR NovoCure Limited | Buy | 7.79% | -0.5% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.68% | 3.45% | 2024-09-09 |
STAA STAAR Surgical Company | Sell | -3.7% | 3.06% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.8% | -1.08% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.64% | 3.06% | 2024-08-29 |
CERS Cerus Corporation | Sell | -3.93% | 2.37% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
MGNX | Sell All | -2.28% |
AADI | Sell All | 7.43% |
TVTX | Sell All | 48.65% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
AADI Aadi Bioscience, Inc. | Buy | 6.31% | 1.14% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.82% | 12.73% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 9.43% | 2.85% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.77% | -4.37% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 9.26% | 31.25% | 2024-09-04 |
NVCR NovoCure Limited | Buy | 7.63% | -3.99% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.37% | -2.15% | 2024-09-09 |
STAA STAAR Surgical Company | Sell | -3.58% | 7.41% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.77% | 0.97% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.38% | 11.39% | 2024-08-29 |
CERS Cerus Corporation | Sell | -3.95% | 3.32% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
AGEN | Sell All | 8.41% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
AGEN Agenus Inc. | Buy | 6.13% | 3.11% | 2024-08-23 |
AADI Aadi Bioscience, Inc. | Buy | 6.59% | 5.14% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.75% | 11.4% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 9.5% | 3.13% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.76% | -4.92% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 9.04% | 27.5% | 2024-09-04 |
NVCR NovoCure Limited | Buy | 7.62% | -4.54% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.38% | -2.56% | 2024-09-09 |
STAA STAAR Surgical Company | Sell | -3.64% | 6.36% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.73% | 2.57% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.34% | 12.76% | 2024-08-29 |
CERS Cerus Corporation | Sell | -3.99% | 2.84% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
VREX | Buy All | 2.22% |
APLS | Sell All | -3.75% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.84% | -1.69% | 2024-08-22 |
AGEN Agenus Inc. | Buy | 5.93% | -0.18% | 2024-08-23 |
AADI Aadi Bioscience, Inc. | Buy | 6.37% | 1.71% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.69% | 10.8% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 9.34% | 1.42% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.7% | -5.46% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 9.47% | 33.75% | 2024-09-04 |
NVCR NovoCure Limited | Buy | 7.47% | -6.37% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.58% | 0.26% | 2024-09-09 |
STAA STAAR Surgical Company | Sell | -3.62% | 6.89% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.71% | 3.03% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.26% | 14.88% | 2024-08-29 |
VREX Varex Imaging Corporation | Sell | -3.98% | 2.99% | 2024-09-05 |
CERS Cerus Corporation | Sell | -3.98% | 2.84% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
CDMO | Buy All | 0.85% |
CARA | Sell All | -18.08% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.93% | 0.21% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 5.35% | -9.62% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.55% | -6.22% | 2024-08-23 |
AADI Aadi Bioscience, Inc. | Buy | 6.45% | 3.43% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.33% | 7.2% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 9.01% | -1.71% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.51% | -7.1% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 9.45% | 33.96% | 2024-09-04 |
NVCR NovoCure Limited | Buy | 7.3% | -7.98% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.58% | 0.63% | 2024-09-09 |
CDMO Avid Bioservices, Inc. | Sell | -3.28% | 15.41% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.59% | 7.17% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.7% | 2.83% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.34% | 12.41% | 2024-08-29 |
VREX Varex Imaging Corporation | Sell | -3.57% | 12.56% | 2024-09-05 |
CERS Cerus Corporation | Sell | -3.91% | 4.27% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
BGNE | Buy All | -0.8% |
PACB | Buy All | -22.96% |
ALDX | Sell All | -6.49% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | Buy | 6.22% | 3% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 5.67% | -6.12% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.47% | -9.51% | 2024-08-23 |
AADI Aadi Bioscience, Inc. | Buy | 6.66% | 4.57% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.34% | 5.05% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 8.67% | -7.41% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.44% | -9.84% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 8.24% | 14.37% | 2024-09-04 |
ALDX Aldeyra Therapeutics, Inc. | Buy | 7.89% | -3.01% | 2024-09-05 |
NVCR NovoCure Limited | Buy | 7.58% | -6.48% | 2024-09-06 |
MYGN Myriad Genetics, Inc. | Buy | 7.69% | 0% | 2024-09-09 |
CDMO Avid Bioservices, Inc. | Sell | -3.3% | 16.54% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.8% | 3.86% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.85% | 1.1% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.41% | 12.41% | 2024-08-29 |
PACB Pacific Biosciences of California, Inc. | Sell | -4.55% | -17.04% | 2024-08-29 |
BGNE BeiGene, Ltd. | Sell | -3.28% | 0.24% | 2024-09-02 |
VREX Varex Imaging Corporation | Sell | -4.11% | 1.28% | 2024-09-05 |
CERS Cerus Corporation | Sell | -3.99% | 4.27% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
ORGO | Sell All | -12.72% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.91% | -1.42% | 2024-08-22 |
ORGO Organogenesis Holdings Inc. | Buy | 5.6% | -6.71% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 5.62% | -6.41% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.48% | -8.59% | 2024-08-23 |
AADI Aadi Bioscience, Inc. | Buy | 6.51% | 2.86% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.34% | 5.72% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 8.95% | -3.7% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 8.74% | -6.01% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 7.4% | 3.44% | 2024-09-04 |
ALDX Aldeyra Therapeutics, Inc. | Buy | 8.08% | 0% | 2024-09-05 |
NVCR NovoCure Limited | Buy | 8.05% | 0% | 2024-09-06 |
CDMO Avid Bioservices, Inc. | Sell | -3.34% | 14.93% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.78% | 3.61% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.82% | 1.07% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.65% | 5.44% | 2024-08-29 |
PACB Pacific Biosciences of California, Inc. | Sell | -4.01% | -3.7% | 2024-08-29 |
BGNE BeiGene, Ltd. | Sell | -3.26% | 0.1% | 2024-09-02 |
VREX Varex Imaging Corporation | Sell | -4.24% | -2.31% | 2024-09-05 |
CERS Cerus Corporation | Sell | -4.08% | 1.42% | 2024-09-05 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.68% | -5.21% | 2024-08-22 |
ORGO Organogenesis Holdings Inc. | Buy | 5.71% | -4.59% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 5.62% | -6.12% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.31% | -11.33% | 2024-08-23 |
AADI Aadi Bioscience, Inc. | Buy | 6.49% | 2.86% | 2024-08-27 |
PODD Insulet Corporation | Buy | 9.17% | 3.96% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 8.78% | -5.41% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 9.23% | -0.55% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 7.48% | 4.69% | 2024-09-04 |
ALDX Aldeyra Therapeutics, Inc. | Buy | 8.07% | 0% | 2024-09-05 |
CDMO Avid Bioservices, Inc. | Sell | -3.42% | 12.67% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.81% | 2.72% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.83% | 0.61% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.69% | 4.42% | 2024-08-29 |
PACB Pacific Biosciences of California, Inc. | Sell | -3.77% | 2.22% | 2024-08-29 |
BGNE BeiGene, Ltd. | Sell | -3.21% | 1.63% | 2024-09-02 |
VREX Varex Imaging Corporation | Sell | -4.13% | 0% | 2024-09-05 |
CERS Cerus Corporation | Sell | -4.13% | 0% | 2024-09-05 |
Asset | Action | Perf % |
---|---|---|
CERS | Sell All | -11.34% |
EGRX | Sell All | -11.35% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.85% | -2.65% | 2024-08-22 |
ORGO Organogenesis Holdings Inc. | Buy | 5.79% | -3.53% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 5.8% | -3.5% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.43% | -9.51% | 2024-08-23 |
CERS Cerus Corporation | Buy | 5.82% | -7.98% | 2024-08-27 |
AADI Aadi Bioscience, Inc. | Buy | 6.29% | -0.57% | 2024-08-27 |
PODD Insulet Corporation | Buy | 8.94% | 1.11% | 2024-08-29 |
EGRX Eagle Pharmaceuticals, Inc. | Buy | 7.92% | -10.38% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 8.7% | -6.55% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 9.31% | 0% | 2024-09-02 |
TVTX Travere Therapeutics, Inc. | Buy | 7.16% | 0% | 2024-09-04 |
CDMO Avid Bioservices, Inc. | Sell | -3.62% | 8.03% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.92% | 0.15% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.8% | 1.75% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.59% | 7.14% | 2024-08-29 |
PACB Pacific Biosciences of California, Inc. | Sell | -3.84% | 0.74% | 2024-08-29 |
BGNE BeiGene, Ltd. | Sell | -3.21% | 1.84% | 2024-09-02 |
Asset | Action | Perf % |
---|---|---|
PINC | Buy All | -4.4% |
VERU | Buy All | -12.35% |
ARDX | Sell All | -11.62% |
NEOG | Sell All | -6.34% |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
ARDX Ardelyx, Inc. | Buy | 5.64% | -2.98% | 2024-08-22 |
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.68% | -2.4% | 2024-08-22 |
ORGO Organogenesis Holdings Inc. | Buy | 5.92% | 1.77% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 6.11% | 4.96% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.48% | -5.85% | 2024-08-23 |
CERS Cerus Corporation | Buy | 5.82% | -5.04% | 2024-08-27 |
AADI Aadi Bioscience, Inc. | Buy | 6.34% | 3.43% | 2024-08-27 |
NEOG Neogen Corporation | Buy | 6.92% | 0.35% | 2024-08-28 |
PODD Insulet Corporation | Buy | 8.5% | -0.81% | 2024-08-29 |
EGRX Eagle Pharmaceuticals, Inc. | Buy | 8.47% | -1.15% | 2024-08-29 |
MGNX MacroGenics, Inc. | Buy | 9.02% | 0% | 2024-09-02 |
ESPR Esperion Therapeutics, Inc. | Buy | 9.02% | 0% | 2024-09-02 |
CDMO Avid Bioservices, Inc. | Sell | -3.8% | 0.38% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.89% | -2.22% | 2024-08-28 |
PINC Premier, Inc. | Sell | -3.92% | -2.93% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.8% | -1.4% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.84% | -2.38% | 2024-08-29 |
VERU Veru Inc. | Sell | -3.79% | -1.23% | 2024-08-29 |
PACB Pacific Biosciences of California, Inc. | Sell | -3.8% | -1.48% | 2024-08-29 |
BGNE BeiGene, Ltd. | Sell | -3.17% | 0% | 2024-09-02 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
ARDX Ardelyx, Inc. | Buy | 5.62% | -3.45% | 2024-08-22 |
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.58% | -4.2% | 2024-08-22 |
ORGO Organogenesis Holdings Inc. | Buy | 6.03% | 3.53% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 6.04% | 3.79% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.44% | -6.58% | 2024-08-23 |
CERS Cerus Corporation | Buy | 5.78% | -5.88% | 2024-08-27 |
AADI Aadi Bioscience, Inc. | Buy | 5.89% | -4% | 2024-08-27 |
NEOG Neogen Corporation | Buy | 6.75% | -2.15% | 2024-08-28 |
PODD Insulet Corporation | Buy | 8.57% | 0% | 2024-08-29 |
EGRX Eagle Pharmaceuticals, Inc. | Buy | 8.57% | 0% | 2024-08-29 |
CDMO Avid Bioservices, Inc. | Sell | -3.68% | 3.4% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.75% | 1.42% | 2024-08-28 |
PINC Premier, Inc. | Sell | -3.82% | -0.3% | 2024-08-28 |
LMAT LeMaitre Vascular, Inc. | Sell | -3.75% | 0% | 2024-08-29 |
AVXL Anavex Life Sciences Corp. | Sell | -3.75% | 0% | 2024-08-29 |
VERU Veru Inc. | Sell | -3.75% | 0% | 2024-08-29 |
PACB Pacific Biosciences of California, Inc. | Sell | -3.75% | 0% | 2024-08-29 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
ARDX Ardelyx, Inc. | Buy | 5.62% | -2.35% | 2024-08-22 |
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.72% | -0.64% | 2024-08-22 |
ORGO Organogenesis Holdings Inc. | Buy | 5.98% | 3.89% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 6.02% | 4.66% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 5.92% | 2.93% | 2024-08-23 |
CERS Cerus Corporation | Buy | 5.91% | -2.52% | 2024-08-27 |
AADI Aadi Bioscience, Inc. | Buy | 5.82% | -4% | 2024-08-27 |
NEOG Neogen Corporation | Buy | 6.82% | 0% | 2024-08-28 |
CDMO Avid Bioservices, Inc. | Sell | -3.66% | 2.74% | 2024-08-26 |
STAA STAAR Surgical Company | Sell | -3.76% | 0% | 2024-08-28 |
PINC Premier, Inc. | Sell | -3.76% | 0% | 2024-08-28 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
ARDX Ardelyx, Inc. | Buy | 5.64% | -0.94% | 2024-08-22 |
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.69% | -0.05% | 2024-08-22 |
ORGO Organogenesis Holdings Inc. | Buy | 6.09% | 7.07% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 6.14% | 7.87% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 6.11% | 7.31% | 2024-08-23 |
CERS Cerus Corporation | Buy | 6% | 0% | 2024-08-27 |
AADI Aadi Bioscience, Inc. | Buy | 6% | 0% | 2024-08-27 |
CDMO Avid Bioservices, Inc. | Sell | -3.65% | 2.08% | 2024-08-26 |
Asset | Action | Weight | PnL | Entry Date |
---|---|---|---|---|
ARDX Ardelyx, Inc. | Buy | 5.71% | -0.31% | 2024-08-22 |
APLS Apellis Pharmaceuticals, Inc. | Buy | 5.76% | 0.64% | 2024-08-22 |
ORGO Organogenesis Holdings Inc. | Buy | 5.93% | 3.53% | 2024-08-22 |
CARA Cara Therapeutics, Inc. | Buy | 5.81% | 1.46% | 2024-08-23 |
AGEN Agenus Inc. | Buy | 6.07% | 6.03% | 2024-08-23 |
CDMO Avid Bioservices, Inc. | Sell | -3.75% | 0% | 2024-08-26 |